| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.003 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |